Literature DB >> 16705436

Transient receptor potential (TRP) channels as drug targets.

Martin C Michel1.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16705436     DOI： 10.1007/s00210-006-0071-4

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  16 in total

1.  TRP channels as new pharmacological targets.

Authors:  Thomas Gudermann; Veit Flockerzi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04       Impact factor: 3.000

Review 2.  Function and pharmacology of TRPM cation channels.

Authors:  Christian Harteneck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04       Impact factor: 3.000

Review 3.  The TRPC2 ion channel and pheromone sensing in the accessory olfactory system.

Authors:  F Zufall
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04       Impact factor: 3.000

Review 4.  TRP channels in airway smooth muscle as therapeutic targets.

Authors:  Martin Gosling; Chris Poll; Su Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04       Impact factor: 3.000

Review 5.  Structure-function analysis of TRPV channels.

Authors:  Barbara A Niemeyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04       Impact factor: 3.000

Review 6.  TRPC3: a versatile transducer molecule that serves integration and diversification of cellular signals.

Authors:  Klaus Groschner; Christian Rosker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04       Impact factor: 3.000

Review 7.  Small molecule vanilloid TRPV1 receptor antagonists approaching drug status: can they live up to the expectations?

Authors:  Arpad Szallasi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-06-14       Impact factor: 3.000

Review 8.  Transcriptional regulation and processing increase the functional variability of TRPM channels.

Authors:  Annette Lis; Ulrich Wissenbach; Stephan E Philipp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04-27       Impact factor: 3.000

9.  Development of the first ultra-potent "capsaicinoid" agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potential.

Authors:  Giovanni Appendino; Luciano De Petrocellis; Marcello Trevisani; Alberto Minassi; Nives Daddario; Aniello Schiano Moriello; David Gazzieri; Alessia Ligresti; Barbara Campi; Gabriele Fontana; Christian Pinna; Pierangelo Geppetti; Vincenzo Di Marzo
Journal:  J Pharmacol Exp Ther       Date:  2004-09-08       Impact factor: 4.030

Review 10.  The overactive bladder: review of current pharmacotherapy in adults. Part 2: treatment options in cases refractory to anticholinergics.

Authors:  Arun Sahai; Mohammed Shamim Khan; Manit Arya; Jason John; Rajinder Singh; Hitendra R H Patel
Journal:  Expert Opin Pharmacother       Date:  2006-04       Impact factor: 3.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.